Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- University of Utah
- University of Copenhagen
- University of Glasgow
- Maastricht University (UM)
- The University of Chicago
- University of North Carolina at Chapel Hill
- Institute of Physical Chemistry, Polish Academy of Sciences
- National University of Singapore
- Universidade do Minho
- University of Washington
- ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA - - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
- Academic Europe
- Amgen Scholars Program
- Aston University
- CNRS
- CRUK Manchester Institute
- California Institute of Technology
- Carnegie Mellon University
- Ecole Supérieure De Biologie Biochimie Et Biotechnologies (Université Catholique de Lyon)
- Eli Lilly and Company
- European Molecular Biology Laboratory (EMBL)
- Florida International University
- Fundación Investigación Biomédica del Hospital de la Princesa
- HHMI
- Institut d'Investigació Biomèdica Sant Pau
- Itä-Suomen yliopisto
- Luxembourg Institute of Health (LIH)
- NIST
- NOVA.id.FCT- Associação para a Inovação de Desenvolvimento da FCT
- Newcastle University
- Research Center for Molecular Medicine (CeMM), ÖAW
- SUNY University at Buffalo
- SciLifeLab
- THE UNIVERSITY OF HONG KONG
- The Ohio State University
- UNIVERSITY OF SOUTHAMPTON
- University Medical Center Utrecht (UMC Utrecht)
- University of Amsterdam (UvA)
- University of Chicago (UC)
- University of East Anglia
- University of Minnesota
- University of Newcastle
- University of Oxford
- University of Pennsylvania
- University of Sheffield
- University of Toronto
- Università Campus Bio-Medico di Roma
- Université Grenoble Alpes
- Uppsala universitet
- Virginia Community College
- 40 more »
- « less
-
Field
-
viability and death assays, in vitro and in vivo drug testing, and molecular biology methods such as qPCR, protein analysis, and light-field/fluorescent microscopy. Design and execute small animal experiments
-
.: 537045), to commence as soon as possible, on a three-year fixed term basis, with the possibility of renewal and consideration for tenure before the expiry of a second three-year fixed-term contract
-
intracellular proteins to induce cancer cell death and manipulate the immune response. We are currently applying new research tools and prototype therapeutics that we, and others, have developed to specifically
-
) transplants. The EIC‑funded HeartVision project aims to change this by developing a method to image heart cells as they function. Heart failure remains the leading cause of death worldwide, and currently
-
difficulties. It is caused by mutations in MRE11, a protein that plays a vital role in repairing damage to DNA. Every cell in the body experiences DNA damage daily, and MRE11 is central to a number of DNA repair
-
, including cell phones & plans, entertainment, health and fitness, restaurants, retail, and travel Professional development opportunities Additional benefits information is available at https
-
UMC, with Dr. Eric Eldering and Dr. Marco Haselager , who bring deep expertise in CLL biology, cell death mechanisms, tumour microenvironment interactions, and therapeutic vulnerabilities. Their close
-
are committed to improving the lives of children through excellence in advocacy, education, research, and clinical care. For more information about the Department of Pediatrics, please visit: http
-
Description Candida albicans is a major human fungal pathogen and the species most commonly associated with invasive candidiasis, a disease estimated to cause nearly one million deaths worldwide each year. A
-
, the temporary Research Scientist/Engineer 2 will work in the Oberst Lab within the Department of Immunology. The Oberst Lab studies programmed cell death and inflammation in models of viral encephalitis